Daphne Hessels

DD3(PCA3), a very sensitive and specific marker to detect prostate tumors.

L. Kiemeney, D. Swinkels, J. Schalken, 2002, Cancer research.

DD3(PCA3)-based molecular urine analysis for the diagnosis of prostate cancer.

J Alfred Witjes, L. Kiemeney, J. Witjes, 2003, European urology.

Polycomb-group oncogenes EZH2, BMI1, and RING1 are overexpressed in prostate cancer with adverse pathologic and clinical features.

J Alfred Witjes, Geert J L H van Leenders, J. Witjes, 2007, European urology.

Detection of High-grade Prostate Cancer Using a Urinary Molecular Biomarker-Based Risk Score.

Geert Trooskens, Wim Van Criekinge, Theo M de Reijke, 2016, European urology.

DD3PCA3-based Molecular Urine Analysis for the Diagnosis of Prostate Cancer

L. Kiemeney, J. Witjes, J. Schalken, 2003 .

The Time-Resolved Fluorescence-Based PCA3 Test on Urinary Sediments after Digital Rectal Examination; a Dutch Multicenter Validation of the Diagnostic Performance

J Alfred Witjes, J. Witjes, J. Schalken, 2007, Clinical Cancer Research.